losartan-potassium has been researched along with Hypopituitarism* in 5 studies
1 review(s) available for losartan-potassium and Hypopituitarism
Article | Year |
---|---|
[Endocrine diseases and hematologic anomelies].
Topics: Adolescent; Adrenocortical Hyperfunction; Adult; Anemia; Anemia, Hemolytic; Animals; Dwarfism, Pituitary; Endocrine System Diseases; Erythropoiesis; Erythropoietin; Female; Hematologic Diseases; Humans; Hypopituitarism; Male; Mice; Pituitary Diseases; Polycythemia; Rabbits; Thyroid Diseases; Thyroiditis, Autoimmune | 1974 |
4 other study(ies) available for losartan-potassium and Hypopituitarism
Article | Year |
---|---|
Effect of long-term treatment with recombinant human growth hormone on erythropoietin secretion in an anemic patient with panhypopituitarism.
We studied the effect of treatment with recombinant human GH in an anemic patient with panhypopituitarism in which hemoglobin (Hb) concentration remained as low as 11.0 g/dl in spite of appropriate replacement with thyroid and adrenocortical hormones. Recombinant human GH was subcutaneously and constantly infused for 12 months using a portable syringe pump at a rate of 0.25 U/kg/week. After the treatment with human GH plasma erythropoietin (EPO) levels increased from 12.2 to 25.1 mIU/ml, with a concomitant increase of Hb concentration to 13.6 g/dl. When the administration of human GH was interrupted, both plasma EPO levels and Hb concentrations decreased. There was a close correlation between plasma GH and EPO levels before and during the human GH administration (y=2.444x+1 3.423, r=0.641, p<0.05). Plasma GH levels were well correlated with Hb concentrations before and during human GH administration (y=0.529x+11.313, r=0.690, p<0.01). Plasma IGF4 levels were also correlated with Hb concentrations (y=0.007x+10.874, r=0.832, p<0.001), but not with plasma EPO levels. These findings suggest that GH treatment may be useful in anemic patients with panhypopituitarism. Topics: Anemia; Erythropoietin; Female; Hemoglobins; Human Growth Hormone; Humans; Hypopituitarism; Insulin-Like Growth Factor I; Middle Aged | 2000 |
Improvement of anemia by recombinant erythropoietin in a patient with postoperative hypopituitarism.
Topics: Adult; Anemia; Erythropoietin; Female; Humans; Hypopituitarism; Postoperative Complications; Recombinant Proteins | 1994 |
Hemopoiesis in pituitary dwarfs treated with human growth hormone and testosterone.
Topics: Anemia, Aplastic; Blood Volume; Bone Marrow; Bone Marrow Cells; Child; Chromium Isotopes; Craniopharyngioma; Dwarfism, Pituitary; Erythropoiesis; Erythropoietin; Growth Hormone; Humans; Hypophysectomy; Hypopituitarism; Iron; Kinetics; Leukocyte Count; Lymphocytes; Male; Radioimmunoassay; Testosterone; Transferrin | 1972 |
Erythropoietin excretion in a hypopituitary patient. Effects of testosterone and vasopressin.
Topics: Animals; Chromium Isotopes; Diabetes Insipidus; Erythropoiesis; Erythropoietin; Hemoglobinometry; Humans; Hypopituitarism; Iron; Iron Isotopes; Male; Mice; Middle Aged; Osmotic Fragility; Plasma Volume; Polycythemia; Serum Albumin, Radio-Iodinated; Testosterone; Vasopressins | 1968 |